Clinico-pathological features of thyroid cancer as observed in five referral hospitals in Iran: A review of 1 177 cases

Acta Oncologica

Volumn 42, Issue 4, 2003, Pages 334-337

  Larijani, Bagher ^a,b   Aghakhani, Shahriar ^a   Khajeh Dini, Hossein ^a   Baradar Jalili, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; PATHOLOGY; TUMORS;

THYROID CANCER;

ONCOLOGY;

ANAPLASTIC CARCINOMA; ARTICLE; CLINICAL FEATURE; DYSPHAGIA; DYSPHONIA; DYSPNEA; ENDEMIC DISEASE; FEMALE; FOLLICULAR CARCINOMA; HOSPITAL; HUMAN; IODINE DEFICIENCY; IRAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; METASTASIS; NECK TUMOR; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CANCER; THYROID CARCINOMA; WEIGHT REDUCTION;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGE DISTRIBUTION; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IRAN; MALE; MEDICAL RECORDS; MIDDLE AGED; PREVALENCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; THYROID NEOPLASMS;

EID: 0037825842     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310001547     Document Type: Article

References (30)

1. Deandrea M, Gallone G, Veglio M, et al. Thyroid cancer histotype changes as observed in a major general hospital in a 21-year period. J Endocrinol Invest 1997; 20: 52-8.
2. Feldt-Rasmussen U. Iodine and cancer. Thyroid 2001; 11: 483-6.
3. Schneider AB, Ron E. Carcinoma of follicular epithelium. In: Braverman LE, Utiger RD, eds. The thyroid, 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 75-6.
4. dos Santos Silva I, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993; 67: 330-40.
5. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15 698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997; 79: 564-73.
6. Mazzaferri EL, Jhiang SM. Differentiated thyroid cancer long-term impact of initial therapy. Trans Am Clin Climatol Assoc 1994; 106: 151-68 (discussion 168-70).
7. Ain KB. Papillary thyroid carcinoma: etiology, assessment and therapy. Endocrinol Metab Clin North Am 1995; 24: 711-60.
8. Grebe SK, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995; 24: 761-801.
9. Bucsky P, Parlowskym T. Epidemiology and therapy of thyroid cancer in childhood and adolescence. Exp Clin Endocrinol Diabetes 1997; 105(Suppl 4): 70-3.
10. Kuijpens JL, Hansen B, Hamming JF, Ribot JG, Haak HR, Coebergh JW. Trends in treatment and long-term survival of thyroid cancer in southeastern Netherlands, 1960-1992. Eur J Cancer 1998; 34: 1235-41.
11. Lorentz TG, Lau PW, Lo CY, Law WL, Wan KY, Lauder IJ. Multivariate analysis of risk factors influencing survival in 110 ethnic Chinese with papillary thyroid cancer. World J Surg 1994; 18: 547-50 (discussion 551).
12. Ferich L, Akslen LA, Glattre E. Increased risk of thyroid cancer among Norwegian women married to fishery workers: a retrospective cohort study. Br J Cancer 1997; 76: 385-9.
13. Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R. Incidence and characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goitre country. Thyroid 1997; 7: 733-41.
14. Kimiagar M, Azizi F, Navai L, Yassai M, Nafarabadi T. Survey of iodine deficiency in a rural area near Tehran: association of food intake and endemic goitre. Eur J Clin Nutr 1990; 44: 17-22.
15. Emami A, Shahbazi H, Sabzevari M, et al. Goiter in Iran. Am J Clin Nutr 1969; 22: 1584-8.
16. Assessment of monitoring of iodine deficiency disorders in countries of the Eastern Mediterranean Region. WHO EMRO. Report of a symposium workshop, 9-11 Sept 1999, Tehran IR Iran, 2000.
17. Azizi F, Kimiagar M, Navai L, Yassai M. Goiter in Tehran and suburbs. Recent progress in thyroidology. In: Vichayanast A. et al., eds. Proc Third Asia and Oceania Thyroid Assoc Meeting 1986; 388-91.
18. Hedinger CE. Histological typing of thyroid tumors. In: Hedinger CE, ed. International Histological Classification of Tumors, vol. 11, 2nd ed. Berlin: Springer Verlag, 1988: 22.
19. Christensen SB, Ljungberg O, Tibblin S. Thyroid carcinoma in Malmo, 1960-1977. Epidemiologic, clinical, and prognostic findings in a defined urban population. Cancer 1984; 53: 1625-33.
20. dos Santos Silva I, Swerdlow AJ. Sex Differences in the risk of hormone-dependent cancers. Am J Epidemiol 1993; 138: 10-28.
21. Ain KB. Anaplastic thyroid carcinoma: behavior, biology and therapeutic approaches. Thyroid 1998; 8: 715-26.
22. al-Nuaim AR, Ahmed M, Bakheet S, et al. Papillary thyroid cancer in Saudi Arabia. Clinical, pathologic, and management characteristics. Clin Nucl Med 1996; 21: 307-11.
23. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 1998; 8: 1179-83.
24. Coard KC. Tumours and tumour-like lesions of bone. The UHWI experience. University Hospital of the West Indies. West Indian Med J 1998; 47: 108-10.
25. Salabe GB. Aetiology of thyroid cancer: an epidemiological overview. Thyroidology 1994; 6: 11-9.
26. Pettersson B, Coleman MP, Ron E, Adami HO. Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 1996; 65: 13-9.
27. Agrawal S, Rao RS, Parikh DM, Parikh HK, Borges AM, Sampat MB. Histologic trends in thyroid cancer 1969-1993: a clinico-pathologic analysis of the relative proportion of anaplastic carcinoma of the thyroid. J Surg Oncolog 1996; 63: 251-5.
28. Azizi F, Kimiagar M, Nafarabadi M, Yassai M. current status of iodine deficiency in the Islamic Republic of Iran. EMRO Health Survey J 1990; 8: 23-7.
29. Danese D, Gardini A, Farsetti A, Sciacchitano S. Thyroid carcinoma in children and adolescent. Eur J Pediatr 1997; 156: 190-4.
30. Ikekubo K, Hino M, Ito H, et al. Thyroid carcinoma in solitary hot thyroid lesions on Tc-99m sodium pertechnetate scans. Ann Nucl Med 1989; 3: 31-6.